Cite
HARVARD Citation
Beuschlein, F. et al. (2016). IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma. Molecular and cellular endocrinology. pp. 82-88. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Beuschlein, F. et al. (2016). IGF1-R inhibition and liposomal doxorubicin: Progress in preclinical evaluation for the treatment of adrenocortical carcinoma. Molecular and cellular endocrinology. pp. 82-88. [Online].